201 related articles for article (PubMed ID: 37526450)
21. Congenital amegakaryocytic thrombocytopenia - Not a single disease.
Germeshausen M; Ballmaier M
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101286. PubMed ID: 34404532
[TBL] [Abstract][Full Text] [Related]
22. Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant.
Zhao C; Bartock M; Jia B; Shah N; Claxton DF; Wirk B; Rakszawski KL; Nickolich MS; Naik SG; Rybka WB; Ehmann WCC; Hohl RJ; Valentin J; Bernas-Peterson M; Gerber EM; Zimmerman M; Mierski JA; Mineishi S; Zheng H
J Hematol Oncol; 2022 May; 15(1):64. PubMed ID: 35590334
[TBL] [Abstract][Full Text] [Related]
23. [From gene to disease; from a thrombopoietin receptor gene defect to congenital amegakaryocytic thrombocytopenia].
van den Oudenrijn S; Bruin M; de Haas M; von dem Borne AE
Ned Tijdschr Geneeskd; 2002 Mar; 146(10):469-71. PubMed ID: 11913111
[TBL] [Abstract][Full Text] [Related]
24. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia.
Ballmaier M; Germeshausen M; Krukemeier S; Welte K
Ann N Y Acad Sci; 2003 May; 996():17-25. PubMed ID: 12799278
[TBL] [Abstract][Full Text] [Related]
25. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
Front Immunol; 2019; 10():334. PubMed ID: 30894856
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic efficacy of second allo-HSCT for aplastic anemia after failure of first allo-HSCT].
Zhu F; Chen HR; Guo Z; Liu XD; He XP; Lou JX; Yang K; Zhang Y; Chen P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1348-53. PubMed ID: 25338587
[TBL] [Abstract][Full Text] [Related]
27. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.
Ballmaier M; Germeshausen M; Schulze H; Cherkaoui K; Lang S; Gaudig A; Krukemeier S; Eilers M; Strauss G; Welte K
Blood; 2001 Jan; 97(1):139-46. PubMed ID: 11133753
[TBL] [Abstract][Full Text] [Related]
28. Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial.
Admiraal R; Nierkens S; Bierings MB; Bredius RGM; van Vliet I; Jiang Y; Lopez-Yurda M; Versluijs AB; Zwaan CM; Lindemans CA; Boelens JJ
Lancet Haematol; 2022 Feb; 9(2):e111-e120. PubMed ID: 35114150
[TBL] [Abstract][Full Text] [Related]
29. Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations.
Savoia A; Dufour C; Locatelli F; Noris P; Ambaglio C; Rosti V; Zecca M; Ferrari S; di Bari F; Corcione A; Di Stazio M; Seri M; Balduini CL
Haematologica; 2007 Sep; 92(9):1186-93. PubMed ID: 17666371
[TBL] [Abstract][Full Text] [Related]
30. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
Theurich S; Fischmann H; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Scheid C; Skoetz N; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2012 Sep; (9):CD009159. PubMed ID: 22972135
[TBL] [Abstract][Full Text] [Related]
31. Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseases.
Gasior Kabat M; Bueno D; Sisinni L; De Paz R; Mozo Y; Perona R; Arias-Salgado EG; Rosich B; Marcos A; Romero AB; Constanzo A; Jiménez-Yuste V; Pérez-Martínez A
Int J Hematol; 2021 Jul; 114(1):116-123. PubMed ID: 33772729
[TBL] [Abstract][Full Text] [Related]
32. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
33. Immune reconstitution in patients with Fanconi anemia after allogeneic bone marrow transplantation.
Perlingeiro Beltrame M; Malvezzi M; Bonfim C; Covas DT; Orfao A; Pasquini R
Cytotherapy; 2014 Jul; 16(7):976-89. PubMed ID: 24831839
[TBL] [Abstract][Full Text] [Related]
34. PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
Hossain MS; Kunter GM; El-Najjar VF; Jaye DL; Al-Kadhimi Z; Taofeek OK; Li JM; Waller EK
PLoS One; 2017; 12(9):e0184254. PubMed ID: 28953925
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
36. MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease.
Germeshausen M; Ballmaier M; Welte K
Hum Mutat; 2006 Mar; 27(3):296. PubMed ID: 16470591
[TBL] [Abstract][Full Text] [Related]
37. Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7.
Steele M; Hitzler J; Doyle JJ; Germeshausen M; Fernandez CV; Yuille K; Dror Y
Pediatr Blood Cancer; 2005 Aug; 45(2):212-6. PubMed ID: 15782403
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
39. T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia.
Bayegi SN; Hamidieh AA; Behfar M; Saghazadeh A; Bozorgmehr M; Karamlou Y; Shekarabi M; Tajik N; Delbandi AA; Zavareh FT; Delavari S; Rezaei N
Transpl Immunol; 2023 Apr; 77():101803. PubMed ID: 36842567
[TBL] [Abstract][Full Text] [Related]
40. Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation.
Ito A; Kitano S; Tajima K; Kim Y; Tanaka T; Inamoto Y; Kim SW; Yamamoto N; Fukuda T; Okamoto S
Int J Hematol; 2020 Jan; 111(1):120-130. PubMed ID: 31641956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
